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ABSTRACT 
The relationship of thyroid and monoamine oxi dase act i vi t y t o 
locomotor responses was in•estigated. 
Locomotor activi ty was measured by use of actophotometers. Four 
mice were placed in the actophotometer and counts were recorded at 
specific time intervals up to two hours. The administration of thyroid, 
M0911, and combined thyroid and M0911 did not alter spontaneous activity 
significantly. 
Monoamine oxidase activity of brains and livers was measured in 
vitro using the Warburg apparatus. The elapsed time for tissue respira-
tion was 28 minutes. Thyroid administration did not alter monoamine 
oxidase activity significantly in liver but brain activity was decreased. 
Therapy with M0911 decreased liver monoamine oxidase activity sharply 
and also depressed brain activity. Combined therapy with thyroid and 
M0911 decreased liver monoamine oxidase activity less effectively 
than M>911 alone. Brain m.onoamine oxidase activity was also depressed. 
No correlation was found to exist between monoamine oxidase 
activity and locomotor responses following thyroid, M0911, and combined 
thyroid and M09ll therapy. 
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I. INTROoucnoN 
The advent of psychic energizers in 1952 represents a new frontier 
in the treatment of primary mental depression. Therapeutic doses in hu-
mans achieved excellent results by elevating the mood of the patient and 
improving psychic energy. Responses to these drugs were correlated with 
the decrease of monoa1Bine oxidase (MAO) activity in the body thereby el-
evating the concentrations of brain and tissue catecholamines. 
Diverse effects have been described following the use of thyroid. 
Among these is the decrease in MAO activity. There have been dissenters 
to this view but the evidence preponderantly favors the assenting view-
point. The precise mechanism which is altered to produce the en~yme 
reduction has not been clatifi&d. 
Theoretically. combination therapy of • MAO inhibitor and thyroid 
should combat' depression more effectively than either alone. lf another 
metabolic effect of thyroid is considered, such as an elevated basal 
metabolic rate, a more potent therapeutic combination should be predicted. 
Inexplicably, this is not the result. Thyroid and MAO therapy produces 
retardation and apathy in depressed patients. 
This investigation is an attempt to resolve the apparent p radox 
by studying the intet-relationships of MAO activity in brain nd U-ver. 
This will be approached by administering thyroid, MAO inhibitor and a 
combination of thyroid and MAO inhibitor to experimental animals • 
.. , 
. ' . 
4 
II. SURVEY OF THE LITERATURE 
At the turn of the century, Eppinger, Falta and Rudinger (cf. Burn 
& Marks, 1925) found that in thyroidectomized dogs an injection of adren-
aline did not cause glycosuria. Burn and Marks (1925) studied the glyce-
mic responses associated with adrenaline and insulin and found an inverse 
relationship resulting from the activity of adrenalin and insulin. Adren-
aline promoted glycogenolysis and insulin produced a hypoglycemic state. 
These investigators also noted that thyroidectomy produces an increase 
in insulin hypoglycemia and a decrease in adrenalin hyperglycemia. Al-
though Burn and Marks did not attribute this phenomena to MAO activity, 
the implication that this enzyme may have been responsible is e•ident 
from subsequent knowledge. 
Interactions of thyroid and sympathomimetic amine1 were found on 
a gross tissue respone level. Sawyer (1935) explored the effects of 
thyroidectomy and thyroxine on the response of the denervated heart to 
injected and secreted adrenaline. Thyroidectomy decreased the response 
of the denervated heart of the cat to injected and secreted adrenaline. 
Their conclusion suggests that the "sensitization" of heart tissue to 
adrenaline is caused by thyroid • . Oehme (1936) reported that the adrenal 
cortical hormone po1sesses an antithyrotropic action as it decreased the 
elevated basal metabolic rate (BMR) in guinea pigs. The action of adren-
al cortical secretion was effective whether the hyperthyroid state was 
caused by parenteral thyroxine or by dietary feeding and furthermore, 
the activity of ascorbic acid paralleled the activity of the horll\One of 
the adrenal cortex. Developing this theory Oehme (1937) eX:perimented 
with thyroid, the adrenal cortex hormone, ascorbic acid and amino acids. 
Tb.e results indicated that the hormone of the adrenal cortex not only 
s 
6. 
lowers the increased metabolism of guinea pigs after thyroxine but also 
prolongs the life span of ani111als poisoned with thyroxine. Glycine ex-
hibited essentially the same effect in experimental hyperthyroidism as 
the adrenal hormone, but in euthyroid guinea pigs it lowered metabolism 
after a prolonged period. Brewster et al. (1956) demonstrated the aug-
mentation of the effects of epinephrine by thyroid. Hyperthyroid animals 
deprived of ~11 sources of epinephrine returned to the euthyroid state. 
These experiments indicate that thyroid sensitizes heart tissue to 
adrenaline. Furthermore, thyroid•s action is inhibited by the hormone 
of the adrenal cortex, ascorbic acid, and amino acids. 
The hypothesis of a possible thyroid-adrenal interplay was dem-
onstrated by the work of Rokhlina (1957). He h~s shown by implantation 
techniques in the chick embryo, that adrenal cort~x tissue implanted in 
the chorio-allantoic envelope of the 8 day embryo inhibited the develop0 
ment of the thyroid gland. The inhibition was especially prominent 12 
to 14 days after incubation. Lang (1938) noted that rats rapidly in-
jected subcutaneously with adrenaline, demonstrated a slight increase in 
the colloid content of the thyroid gland with concomitant proliferation 
of the epithelium. Hoen (1939) determined hormonal relationships between 
the thyroid and adrenal glands. He found that desoxycorticosterone in-
hibited the metabolic effect of thyroxine but did not prevent the loss 
of weight orpro!ong the survival of rats. The hypertrophy of the adren-
als in the hyperthyroid state ~as inhibited by the adrenal hormone and 
the same type of hypertrophy was observed in hypophysectomized rats. 
The inhibition of the thyrotropic stimulating hormone by thyroxine is 
accompanied by a release of cort i cotropic hormone which causes adrenal 
hypertrophy. Goetsch (1940) attempted to implant adrenaline pellets on 
7. 
the thyroid of guinea pigs but was not successful. Using adrenaline in 
oil, rabbits were injected daily for 71 days and differences in thyr oid 
mitochondria were observed in the experimental and cont rols. The change 
in the size of the mitochondri a was deemed stimulat ion . Five years 
earlier Richter (1935) s t udied the effects of thyroid treatment on the 
production and discharge of adrenaline. This i nvestigation demons t rated 
the increase in synthesis and discharge of adrenaline followed by adrenal 
exhaustion. Splanchnic sectioning did not alter the effect and thyroid-
ectomy resulted in rapid formation of adrenaline but no discharge of the 
hormone. Insulin increased the secretion of adrenaline leading to ex-
haustion. 
The scope of thyroid investigations has been kaleidoscopic. At-
tempts to correlate its activity on the tissue level have taken many 
tangents. There has been no formalization of approach and therefore 
the problem has been attacked from various directions. The results of 
the experiments previously cited may have been influenced by oral feed-
ing (Barker, 1951). The marked weight loss following the feeding if 
diets containing 0.1 to 1.0 percent desiccated thyroid plus added vitamins 
disturbs the caloric balance. As the hyperthyroid state develops, the 
amount of thyroid ingested is increased leading to liver damage (Frazier, 
1935; Haban, 1935 and Bartlett, 1938; cf. Barker, 1951). 
Interest in enzyme interactions led to an investigation by Bacq 
(1936). This investigator found a prolongation of responses to sym-
pathetic nerve stimulation after pyrogallol administration. The ef -
fect was attributed to the auto-oxidant properties of the catechol. 
Barker (1951) states that liver cytochrome oxidase, succinic oxidase, 
and d-amino acid oxidase systems were more active after the administra-
a. 
tion of thyroid. Dehydrogenase activity was reduced by thyroidectomy and 
had the opposite effects. Blaschko and Schlossman (1940) corroborated 
these findings with the specification that cytochrome oxidase oxidation 
of adrenaline is augmented by thyroxine, dried thyroid or the thyroid 
stimulating hormone (Tipton and Nixon, 1946). 
Investigations into the effects of thyroid and MAO interactions 
were reported by Spinks and Burn (1952). They found that MAO activity 
was increased in thyroidectomized rat s . A decrease in the activity of 
MAO activity followed thyroid f eeding. Spi nks and Bur n a lso postulated 
that amine oxidase levels were respons i ble for the reduction of adren-
aline hyperglycemia with thyroidectomy and the elevation of adrenaline 
hyperglycemia with thyroid feeding. 
Zile and Lardy (1959) using rat liver mitochondria, demonstrated 
that thyroid feeding decreased MAO activity but no observable change was 
elicited after thyroidectomy. Using thyroid in vitro, no direct inhibit-
ing effect could be shown manomatrically. Further work by Zile (1960) 
and Dubnick et al. (1960) demonstrated the effect of thyroxine and 
other thyromimetic compounds on heart MAO activity. Zile contends 
that no measurable change of heart MAO activi ty was apparent in the 
rat. Changes in the brain were inconsis ent. Upon doubling the dose, 
no further decline in MAO was demonstr ated. Dubnick et al. (1960) 
demonstrated a decrease in br ain MAO activity fol lowing thyro i dectomy. 
The work of Novick (1961) substanti ated the experi ments of Zile and 
Lardy (1959) in one aspect. Using manomet r i c methods, Novick reported 
that a 2 percent des i cated thyroi d diet r educed the MAO activity of 
the livers by 50 percent. This i nvestigat or 's experimental results 
with heart MAO activity apparently conflicted with those of Zile (1960). 
9. 
Thyroid feeding or administration of L-triiodothyronine did not decrease 
MAO levels in the heart but instead increased the content. Novick also 
observed oxygen stimulation of various substrates to different degrees. 
In 100 percent oxygen the uptake of oxygen was elevated by a factor of 
2. Serotonin, the substrate used by Zile (1960), was shown to be stim-
ulated in a total oxygen atmosphere by a factor of 1.4. 
-
Skillen et al. (1962) made an important contribution by eval-
uating the effect of thyroid on MAO in male and female rats. Male rats 
possess greater heart MAO activity than females with no difference in 
5-hydroxytryptophan decarboxylase or S- hydroxytryptamine levels. Thyroid 
feeding did not lower heart MAO in males but did elevate MAO levels in 
females. Chemical thyroidectomy, by the administration of propyl-
thiouracil, decreased male heart MAO activity .but did not alter female 
activity. This work skillfully correlates the work of Novick, Zile, 
and Zile and Lardy. Novick used mixed sexes; Zile and Lardy used male 
rat . • 
Other paradoxical events have contributed to the argument. Five 
hours after the administration of an MAO inhibitor, trans-2-phenyl-
cyclopropylamine, norepinephrine levels were shown to be falling at a 
time of complete MAO inhibition. If a feedback mechanism to arrest 
further synthesis becomes operable, there should be a leveling of nor-
epinephrine levels but not a decline. The alternative would be another 
pathway of metabolism such as the catechol-0-methyl transferase (CDMT) 
system as suggested by Axelrod (1957). 
Ostensibly, MAO activity is modified by MAO inhibitors and the 
amount of inhibition of MAO should correlate with the effect, but there 
are dissenting views. Euler (1955), Corne and Graham (1957), Axelrod and 
10. 
Larouche (1959), Axelrod et al. (1959), and Kopin (1960) suggest that 
deamination is a minor pathway of administered catecholamines. The fact 
that CX>MT is mainly responsible for the degradation of epinephrine is a 
view held by Axelrod (1957) and Axelrod and Tomchick (1958). Grieseme.r 
et al. (1953) and Brown and Gillespie (1957) believe that exogenous and 
endogenous catecholamines are not prolonged in their action by MAO in-
hibitors. They further state that more than one- half of the epinephrine 
and norepinephrine is conv rted to metanepbrine or normetanephrine in 
two minutes. This implicates CX>MT as the enzyme which terminates most 
of the activity of epinephrine and norepinephrine. 
Axelrod et al. (1959), with infusion techniques. found that the 
concentration of epinephrine localized in heart, spleen, adrenals, and 
pituitary exceeds plasma levels several told. Muscle and brain epineph-
rine levels were lower than the plas1na. Metanephrine concentration was 
comparable to epinephrine in all tissues, but higher in skeletal muscle. 
When epinephrine was injected rapidly, the concentration of metanephrin 
was much higher than epinephrine particularly in heart, lung, liver and 
muscle. In the pituitary, however, epinephrine levels were higher than 
metanephrine levels. Plasma al o exhibited higher metanephrine levels 
with a trace of mandelic acid derivatives. Since epinephrin~ was found 
to be in lower concentrations after rap d injections, it was postulated 
that epinephrine was bound after fast injections and then released for 
metabolism. Bpinephrine's biphasic degradation .was also noted. The 
first phase, which was rapid, is explained by diffusion into the tissues 
and 0-methylation. The second phase consists of the release of epineph-
rine from the binding sites and concomitant metaboli m. This information 
suggests strongly that o- methyl tion is a major degradative pathway for 
11. 
the catecholamines. 
If MAO is considered a secondary path of metabolism of the cat-
echolamines. MAO inhibitors would not be expected to elevate catechol-
amine levels significantly. Reports of increased levels of catechol-
amines and the potentiation of effects of catecholamines have been made 
by Pletscher (1957), Glylys et al. (1959), and Burford et al. (1960). 
Serotonin levels have been incr~ased after 24 hours us ing an irrevers-
ible inhibitor, phenelzine. When these levels receded, a dose of a 
short acting inhibitor, harmaline, produced a booster effect (Dubnick 
et al., 1962). It may be questioned as to whether 100 percent in~ 
hibition had been achieved. Spector et al. (1960a) consider the rise 
in serotonin with phenylalkylhyarazines unusual when compared with 
iproniazid, since the amount of MAO in the brain is almost completely 
inactivated. The possibility of inacessibility of MAO to iproniazid 
is considered primary. The function of MAO is seen as an intracellular 
deactivation mechanism for the amines in neurons to prevent spillage 
onto receptor sites. If the MAO is located in the same neuron as nor-
epinephrine, epinephrine, and serotonin, the amines are limited in ac-
tion when storage sites are saturated. The delay in effect of MAO in-
hibitors after blockade is ostensibly caused by the lag in the filling 
of the storage sites and the eventual overflow onto the receptors. The 
pharmacological effect is seen only after the amines have reached a 
maximal concentration. 
The suggestion of Dubnick et al. (1962) is somewhat contradicted 
by an earlier report of Weissbach et al. (1961), postulating the presence 
of variable low levels of MAO in the brain which are insensitive to MAO 
inhibitors. The enzyme can catalyze the fortnation of S~hydroxyindole 
cetic acid. 
'lb.e fact that the physiologic 1 action of MAO inhibitor• are not 
manif et unleaa th nz)'ll\ 11 inhibited 85 percent or more ha b n re-
ported by G y and Pl tacher (1961) and Cheaain et al. (1959). Since 
MAO la lieved to be stored in granuleft (Gi rman and Schanberg, 1958; 
Walaaeaek and Abood, 1959), it i poa ibly protected trom enaymic tr ne~ 
formation. Gey and Pletacher (1961) auggeat that HAO i pres nt in ex~ 
c a in rat brain and the function of the enzyme ia to inactivate fr 
amines rather th.an to regulate total amin 1. 
Major actions ~hich do not involY inhibition of d amination hav 
been attt•ibut d to MAO inhlbitora. 'l'he "true" action ot! MAO ia.b.:lbitor. 
was emphasiz d by O en nd Brickaon (1960), who observed the f lling of 
norepinephrln le•al1 after MAO had b en completely blocked. Axelrod 
et al. (1961) uaing long and hort acting MAO inhibitors and tritiumw 
labeled epinephrine demonstrated that epinephrine haa a dipha1ic 
degradation curve after treatment with rea rpine. The MAO inhibitor• 
did not vary the rapid phase of degradation but xtended the slow 
degradation curve. Axelrod int rpreted thi1 as an inhibition of 
' 
reeerpi • release ot catechol mine• from their binding sites. Spector 
et al. (1960), uaing a blood platelet 1y1t m, refuted r serpln block 
ae a mechanism of action of MAO inhibitor1. 
Th fact that thyroid reinforce• the ffecta of pinephrine 
(Thibault, 1948) and reduces the MAO 1 vela in varioua ti11u a display• 
the importance of thia interr lationahip. Epinephrine haa b n shown 
to stimulate th release of triiodothyronine and t traiodothyronin in 
dogs u1ing th 1 v 1 ot prottin bound iodine (PDtl31) in th thyroid 
vain aa criteria (Ackerman and Arone, 1958). 1ncrea1• in PBil31 l vela 
after injections of 6pinephrine ranged from l.S to 17.l ti.mes the control 
values. The thyroid stimulating hormones increased PBt 131 secretion 7.4 
to 18.9 times that of the controls. Increases in PBI131 were comparable 
in the hypophysectomized dog indicating a direct e feet on the thyroid. 
The fact that Axelrod et al. (1959) observed that the highest amount of 
brai.n epinephrine is found in the pituitary gives an indication of the 
complexity of the modifying influences on the pituitary hormonal picture. 
With the advent of the psychic energizers, an enigmatic response 
was noted by Kline (1961) • . The combination of the psychic energizer 
with thyroid extract produced a retardatioa and apathy in depressed 
patients. The basis 'for this action is not kno'Wll and generally unexplored. 
Ill. lNVESTIGAnON 
A. Objectives 
The tact th t thyroid extract and MAO inhibitors combined cause 
a retardation in the mental h alth of the depressed patient has been 
considered a paradox since each singly produces the opposite effect. 
There has not been an attempt to relate the cause of the retardation and 
apathy with locomotor activity and enzyme levels. 
Specifically, the object of this investigation is to analyze the 
unpredictable responses observed when thyroid and MAO inhibitors are ad~ 
minist red concurrently. 1 L&comotor activity experiments were performed 
on mice after the administration of thyroid, M0911. and combined thyroid 
and M0911. F\lrthermore, MAO enzyme activity was determined at the con .. 
clu1ion of the locomotor studies. The results of these experim nts 
showed the role of MAO in apathetic response associated with MAO in-
hibitors and thyroid combined therapy. 
Locomotor relationships were evaluated by the use of actophotom-
eters.1 The actophotometer ia suited for locomotor studies since. it 
records animal movements by a light beam interruption technique. A 
light beam with a red filter energize photo-electric cells. The an-
imals ' movements will interrupt the beam indicating a pulsating voltage. 
The number of the pulsations is counted and is used as an index of 
activity. Thi technique offers n indirect qu ntitation of central 
nervous system activity. 
B. Materials and Methods 
1. Group Selection and Actophotom ter Calibration: 
1. Actophotometer, Metro Industries, Long Island City, N.Y. 
14 
15. 
Male mice weighing 19-25 grams were placed in each of four acto-
photometers, distributed 6, 5, 4• and 3 in each cage. Counts were taken 
at specific time intervals up to 2 hours . These counts were recorded and 
plotted on semilog paper to determine the ratio of change during each 
time interval. 
The relationships showed that 3, 4, S , or 6 animals could be 
used. Four animals were selected because of convenience in ease of 
handling. 
The actophotometers were located in a soundproof room and counts 
were obtained in total darkness. All counts were taken at approximately 
the same time each evening. The temperature variance of the room from 
eoop. was mi.niinal. 
Calibration of the actophotometers was accomplished by rotating 
an implement around the inner circumference in such a manner that S 
rotations produced a count of 60. Identical counts were obtained by 
the adjustment of the sensitivity. 
2. Drugs: 
Forty-eight male mice were divided into three sections of six-
teen animals. Bach section was subdivided into 4 groups of four animals 
designated I, II, III, IV. One group in each section, or a total of 
twelve animals, served as controls. Section I received 1 mg/kg des-
iccated thyroid intraperitoneally. Section II 'and III received 6 mg/kg 
N-benzyl-N-methyl-2-propynylamine hydrochloride (M:>911) a non-hydrazine 
MAO inhibitor, and combined administration of desiccated thyroid and 
M:>911 respectively.l Injections were administered daily. 
1. The structural formula for M0911 appears in the Appendix. 
16. 
Desiccated thyroid was suspended in physiological saline and ad-
ministered intraperitoneally. Kl911, which is very soluble (1.6 g/ml) 
in water, was also administered intraperitoneally. Controls received 
sham injections of the vehicle. Upon introduction of combined therapy, 
the control mice were injected with an amount of water equivalent to 
the total fluid intake of the mice. 
3. Locomotor Determinations: 
Four male mice were placed in each of four actophotometers. After 
equilibrating for 15 minutes, the counters were activated and counts 
taken at 5, 10, 20, 30, 60, and 120 minutes. The temperature of the 
activity room was recorded throughout the experimental period by util-
izing a Tempscribel thermometer. 
The basis of comparison of the two groups, the experimental and 
controls, was the student "T" test as modified by Snedecor (1956). The 
formula utilized is: 
n(n - 1) 
~2 
or 
n1n2Cn1 + n2 - 2) 
(n1 - n2) ~x2 
i1 - x2 designates the difference between the two group means. 
~x2 is the pooled sum of the squares. 
Actophotometer experiments were initiated 24 hours after injection 
of a specific drug. Drug dosages were administered following the removal 
of mice from the actophotometers. Activities were tested daily 24 hours 
1. Tempscribe, Bacharach Industrial Institute, Pittsburgh, Pa. 
17 • • 
subsequent to injections. Sham controls were used throughout the period 
of investigation. 
4. MAO Analysis: 
MAO activity was determined by the method of Creasey (1956) and 
the mitochondrial-microsomal preparation according to Hawkins (1952). 
Hawkins (1952) indicated that two thirds of the MAO activity is present 
in the mitochondria and the remainder is present in the microsomes . 
Male mice were decapitated and the brains and livers were removed. 
The tissues were frozen by immersion into a freezing slush of dry ice 
and trichloroethanol. The tissues were kept in a freezer and MAO ac-
tivity was analyzed within 30 days. 
Crushed ice was used throughout the period of preparation of 
mitochondria and microsomes to obtain maximum yields of MAO activity. 
All implements utilized in preparing the tissues were placed in crushed 
ice. 
The frozen tissues were weighed on a tissue balance1 and minced 
with scissors while in isotonic sucrose (0.2SM) and the resulting pulp 
was transferred to a homogenizing flask. An amount of isotonic sucrose 
was used in a ratio of 6:1 with the tissue. The homogenates were pre-
pared with a teflon and pyrex homogenizer.2 The homogenate was then 
transferred to a refrigerated centrifuge3 and centrifuged at 755 x g 
for 10 minutes. This procedure sedimented the unbroken cells, the 
incompletely homogenized cell fragments, the nuclei, and red blood 
cells. 
1. Vereenigde nraadfabrie Ken Nijmegen, Holland. 
2. Tri R Homogenizer, Tri~R Instruments, Jamaica, N. Y. 
3. Servall Refrigerated Centrifuge, Model RC-2, Ivan Ser.vall Inc., Nor-
walk, Conn. 
18. 
The supernatant containing the soluble cell constituents includ~ 
ing the microsomes and mitochondria was decanted. This fraction was 
centrifuged at 22,000 x g for 45 minutes in order to separate the 
soluble proteins from the formed elements. The pellet formed con-
sisted primarily of the mitochondria and microsomes. The supernatant 
was carefull discarded and cold sucrose added so that the mitochondri.a-
microsome mixture was equivalent -to 200 to 350 mg of fresh tissue. 
MAO activity was determined by use of the Warburg apparatus. 1 
The main compartment of the conical flask contained l ml of the pro~ 
tein, 0.2 ml of 0.24M sodium phusphate buffer (Dawson, 1959) pH 7.3, 
and 0.2 ml neutralized semicarbazide. Water was added to bring the 
final volume to 2.S ml. The side arm contained 0.4 ml of o.OSM 
tyramine hydrochloride as the substrate or 0.4 ml water in the con~ 
trots. Carbon dioxide absorption was facilitated by 2M KOH in the 
center well. Filter paper with accordian folds was placed in the 
center well extending approximately 1-2 mm above the lip to increase 
the surface area of the KOH. The analysis was performed at 38° 
Centigrade and the preparation was gassed with oxygen (2 liters/min.) 
for 2 minutes. Five flasks were -used per assay consisting of three 
experimental , two controls and one thermo~barometer. Readings were 
taken at four minute intervals .and total time was 28 minutes. Ex-
trapolation of time to one hour was achieved by use of the derived 
equation. 
MAO catalyzes the reaction: 
1. Bronwill Scientific Inc., Rochester, N.Y. 
19. 
Theoretically one molecule of oxygen is absorbed for each mole of sub-
strate deaminatedo The work of Kohn (1937), Pugh and Quastel (1937), 
and Luschinsky and Singher (1945), demonstrated that crude MAO prepara-
tions contain peroxidases and aldehyde oxidase which elevate the theo~ 
retical values of MAO activity. Creasey (1956) demonstrated that semi~ 
carbazide reduces the spontaneous oxidation of the aldehyde (para-
hydroxyphenylacetaldehyde). Aldehyde oxidase was found not to affect 
thi.s system. The schematic representation of the oxidation of tyramine 
substrate is depicted in Figure l . 
Total respiration was determined by the method of Umbreit (1957). 
IV. RESULTS 
All tables and figures are contained in this section. 
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TABLE 1 
Oxygen Uptake of Livers Treated with Thyroid, M09ll, and Combined M0911 and thyroid 
)11 02 Uptake pl 02 Uptake )ll 02 Uptake 
Time Thyroid Section Control M0911 Sect1on--Contro1 M0911-Thyroid cOntrol 
4 min. 11.3 12.4 0.22 12.8 3.9 17.0 
8 min. 18.6 19.9 1.2 21.6 6.4 24.6 
12 min. 25.7 26.5 2.9 28.3 9.2 29.9 
16 min. 32.l 31.8 1.7 36.2 10.6 37.0 
20 min. 37. 7 36.4 1.4 42.9 12 . 4 41 .8 
24 min. 40.6 42.l 2.1 50.0 13.6 47.5 
28 min. 45 .6 45 .4 3.0 55.6 20.1 54.8 
"' ...... 
• 
TABLE 2 
Brain Respiration 
Percent K>9l-1----~----- Percent 
Thyroid pl 02/hr. Decrease Section )(11 02/hr. Decrease 
Control 12.6 0 Control 49.6 0 
Group I 2.4 81 GrOUf l +. 2.8 100 
Group II 9.6 24 Group Ill 1.3 97 
Group III 16.4 .. 30 Group IV 12.2 75 
Thyroid-
M0911 pl 02/hr. 
Control 22.6 
Group I 3.9 
Group III + 3.4 
Group IV 5.2 
Percent 
Decrease 
0 
83 
100 
77 
N 
f\,) 
• 
TABLE 3 
Average Percentage Change of Actophotometer Counts of Mice Treated with Desiccated Thyroid 
15 mln.* SD t p 25 mln. SD t p 
Control 101 16.6 
- -
83 25.6 
0.400 
Group I 108 29.9 0.638 >o. so·o 96 35.l 0.928 0.200 
0.05 
-
Group II 71 . 10.6 2.544 0.025 80 I 14.8 0.177 '>0.500 
0.400 0.400 
-
Group III 89 30.7 1.087 0.200 102 43.5 1.186 0.200 
1i5 min;---- ----SD t p -- - - - - --90 tiii.n. SD t p 
Control 119 22.6 
- -
89 18.3 
o.soo 
-
Group I 97 30.5 0.851 0.400 83 19.8 0.684 >o.5oo 
Group _ _!! 121 29.8 0.053 .> 0.500 93 26.3 0.150 -==so. 500 
---·-----
o.500 o.soo 
- -
Group III 98 38.2 0.812 0.400 109 76.2 0.800 o.4oo 
IV 
* represents mid point of time interval SD - Standard Deviation VI • 
" t" - t value P - P value 
TABLE 4 
Average Percentage Change of Actophotometer Counts of Mice Treated with M0911 
Is m.ln.* SD t p 25 min. SD t p 
Control 93 17.6 
- -
93 12.4 
0.400 
Group I 101 21.2 0.141 > o.500 98 16.0 1. 106 0.200 
0.400. 0.400 
-
Group III 93 15.9 1.106 0.200 99 15.7 1.264 0.200 
0.400 
Group IV 100 23.6 1.050 0.200 9ll. 23.1 0.340 >o.soo 
4.5-miii; - sn- - t p - · 90 -nif.n. SD t p 
Control 86 20.6 
- -
104 49. 7 
0.500· 
-
Group I 92 21.0 0.705 0.400 103 15.l 0.360 >0.500 
0.200 
-
Group III 96 
--- ------------
14.6 1.665 0.100 98 9.1 0 .186 >0.500 
0.400 
-
Group IV 87 24.2 0.145 > o.500 93 37.2 1.012 0.200 
IV 
* represents mid point of time interval SD - Standard Deviation ~ . 
""t 0 ' - t value P - P value 
TABLE 5 
Average Percentage Change of Actophotometer Counts of Mice Treated with M0911 and Desiccated Thyroid 
is mrn.* SD t p 25 min. SD t p 
Cont.rol 94 14.0 
- -
99 11 . 7 
Group I 86 10.6 0.253 ;>0.500 106 47.2 0.5.56 >0. 500 
o.soo 
.... ' ..... 
Group Ill 88" · 13.8 0.354 ~o. soo 103 ,;, 13.'6 0.768 0.400 
o.4oo 
Group IV 90 21.5 0.175 o.soo 89 21.9 0.99 0.200 
liS -inrn;- --- SD t p -- - --- -- - 90--aiin. SD t p 
Control 107 26.4 
- -
104 28.8 
Group I 116 77 . 5 0.115 .> o.soo 105 74 . 8 0.0919 > o.soo 
Group Ill 95 9.1 0.415 > o.5oo 93 B.5 0.347 >0.500 
0.100 0.100 
~ -
-
Group IV 84 30.7 1.93 o.oso 79 35.7 1.89 o.oso 
"" IJt 
* represents mid point of time interval SD - Standard Deviation . 
"t" - t value p - P value 
ll)Oca2.CH2.Nu2.u:z0+02 
Tyramine 
MAO 
26. 
Aldehyde Oxidase 
+ 
Peroxidase + H~2 
Cytochrome System 
lllOCH2.ooou 
~-~--~~~~~~-----
S po n tan e o u ;y- Oxidation 
Brown Pigment 
Fig. l. Tyramine deamination by monoamine oxidase. 
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Fig. 2. Oxygen uptake of liver homogenates from mice treated with thyroid. 
Each point represents the average oxygen uptake of 12 mouse 
liver homogenates analyzed manometrically. The calculated 
equation for the regression line is Ye = 4.4 + l.6X by the 
method of least squares. 
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Fig. 3. Oxygen uptake of liver homogenates of the non-treated mice used 
in parallel studies with thyroid. 
Bach point represents the average oxygen uptake of 4 mouse liver 
homogenates analyzed manometrically. 
The calculated equation for the regression line is Ye = 5.1 + 
l.6X by the method of least squares. 
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Time (minutes) 
Fig. 4. Oxygen uptake of liver homogenates from mice treated with M:>911. 
Each point represents the average oxygen uptake of 12 liver 
homogenates analyzed manometrically. 
The calculated equation of the regression line is Ye = 0.32 + 
0.089X by the method of least squares. 
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Fig. s. Oxygen uptake of liver homogenates of the non-treated mice used 
in parallel studies with M0911. 
Each point represents the average oxygen uptake of 4 mouse liver 
homogenates analyzed manometrically. The calculated equation for 
the regression line is Ye = 4.0 + l.9X by the method of least 
squares. 
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Fig. 6. Oxygen uptake of livers treated with M>911 and thyroid. 
Bach point represents the average uptake of 12 mouse liver 
homogenates ana·lyzed manometrically. 
30 
The calculated equation for the regression line is Y = 0.83 + 
0.62X by the method of least squares. c 
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Fig. 7. Oxygen uptake of liver homogenates of the non-treated mice used 
in parallel studies with M0911 and thyroid. 
Bach point represents the avet'l!l.ge oxygen uptake of 4 mouse liver 
homogenates analyzed manometrically. 
The calculated equation of the regression line is Ye = 6.8 + 
l.77X by the method of least squares. 
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Fig. a. Relationships of locolllCl)tor activity of nor11al mice and 
thyroid treated mice. 
The values of the abscissa represent time. The ordinate 
values indicate the per~entage change of activity variance 
from the control depicted as 1003. 
The interrupted lines are the standard deviations of the 
controls. Solid bars are the standard deviation of th~ 
experimental. 
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Fig. 9. Relationships of locomotor activity of normal mice and 
thyroid treated mice. 
The values of the abscissa represent time. The ordinate 
values indicate the percentage change of activity var-
iance from the control d~picted as 100%. 
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Fig. 10. Relationships of locomotor activity of normal mice 
and thyroid treated mice. 
The values of the abscissa represent time. The 
ordinate values indicate the percentage change of 
activity variance from the control depicted as 100%. 
The interrupted lines are the standard deviations 
of the controls. Solid bars are the standard 
deviation of the experimental. 
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Fig. 11 . Relationships of locomotor activity of normal mice 
and M0911 treated mice. 
The values of the abscissa represent time. The 
ordinate values indicate the percentage change of 
activity variance from the control depicted as 1003. 
The interrupted lines are the standard deviations of 
the controls. Solid bars are the standard deviation 
of the experimental. 
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Fig~ 12. Relationships of locomotor activity of normal mice and 
M0911 treated mice . 
The values of the abscissa represent time. The ordinate 
values indicate the percent age change of activit y var-
iance from the control depicted as 100%. 
The interrupted lines are the standard deviations of 
the controls. Solid bars are the standard deviation 
of the ~xperimental. 
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Fig. 13. Relationships of locomotor activity of normal mice 
and M0911 treated mice. 
The values of the abscissa represent time. The 
ordinate values indicate the percentage change of 
activity variance from the control depicted as 1003. 
The interrupted lines are the standard deviations 
of the controls. Solid bars are the standard devia-
tion of the experimental. 
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Fig. 14. Relationships of locomotor activity of normal mice 
and M091.l-thyroid t.reated mice. 
The values of the abacissa represent time. The 
ordinate values indicate the percentage change of 
activity variance from the lontrol depicted as 1003. 
The interrupted lines are the standard deviations of 
the controls. Solid bars are the standard deviation 
of the experimental. 
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Fig. 15. Relationships of locoaotor activity of normal mice 
and M0911-thyroid treated mice. 
The values of the abscissa represent time. The 
ordinate values indicate the percentage change of 
activity variance from the control depicted as 1003. 
The interrupted lines are the standard deviations of 
the controls. Solid bars are the standard deviation 
of the experimental. 
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Fig. 16. Relationships of locomot9r activity of normal mi ce 
and M09111othyroid treated mice. ' 
The values of the abscissa represent time. the 
ordinate values indicate the percentage change of 
activity variance from the control depicted as 1003. 
The interrupted lines are the standard deviations 
of the controls. Solid bars are the standard devia· 
tion of the experimental. 
V. DISCUSSION 
Thyroid administration elicited :changes in locomotor activity 
but not to any great extent. In group I (Figure 8), the 10-20 minute 
average was 7 percent above that of the control which was not statistic-
ally significant. This indicates that locomotor activity of the control 
and the experimental at this time interval were not significantly dif-
ferent. The actophotometer counts which are an indication of central 
nervous system activity did not deviate significantly from the controls 
throughout the various time intervals. 
Comparisons of the t~ remaining experimental groups yielded the 
same information except in one instance. In the first time interval 
the activity in group II (Figure 9) was depressed. Following this de-
pression, the activity returned to values within the control levels. 
Since the depression was not apparent in the other experimental group 
and did not persist for a reasonable time interval, the interpretation 
that thyroid administration was the causative factor is not justified. 
This transient effect is apparently caused by a lag in equ~libration 
of this group of animals to the actophotometers or by the increased 
social activity of the mice. 
Generally, thyroid at .the dosage employed did not increase no~- de­
crease locomotor activity as measured by actophotometers (see Table 3 and 
Figure 10). The thesis that thyroxine acts by uncoupling oxidative phos-
phorylation (Lipmann & Dutoit, 19Sl; _Matuis & Hese, 1951; and Lardy & 
Maley, 1954) with concomitant production of a higher metabolic rate may sug-
gest that thyroid's systemic effects should produce a measurable rate of de-
creased locomotor activity. Uncoupling oxidative phosphorylation re-
leases the regulatory mechanism for maximum utilization of energy rich 
42 
43. 
bonds and prevents ADP rephosphorylation. 
Administration of MJ911 did not increase locomotor activity 
(Figures ll-13). During all time intervals the response of the experi-
mental animals was not different than that of the controls (see Table 4). 
Wiegand and Perry (1961) stated that no behavioral changes were elicited 
by treatment with M>911 alone. Upon addition of DL-dihydroxyphenylala-
nine {DL JX>PA) after pretreatinent with M09ll. an increase in activity 
and aggressiveness was noted. They suggest that the increased ac-
tivity is due to increases in dopamine or norepinephrine. Carlson et 
al. (1959) (cf. Wiegand and .Perry, 1961) agree with this hypothesis 
after measuring dopamine and norepinephrine levels in mice 6 hours 
after MAO inhibition. 
The latter proposal .is contradicted by the evidence of Everett 
and Wiegand (1961). These investigators demonstrated a gradual increase 
in central amines along with increasing motor activity and aggressive-
ness. Their effects were also augmented after giving DOPA. This may 
be the pivotal statement. 
The postulated correlation of increased locomotor activity and 
aggressiveness with dopamine or norepinephrine appears reasonable, but 
the fact that precursors must be added to initiate increased activity 
indicates that the rate of -synthesis of the catecholamines is not suf-
ficient to elevate norepinepbrine levels or that inhibition of MAO 
does not affect catecholamine metabolism to a significant degree in 
brain tissue. If this hypothesis is accepted then the lack of loco-
motor activity of the experimental animals versus the controls is not 
enigmatic. 
Taylor and Krause (1962) have invalidated arguments concerning 
the possibility that M0911 does not cross the blood brain barrier. 
44. 
c14-labeled N>911 was found in adequate concentrations in the brain of 
rats and dogs, with detectable amounts up to 48 hours in rat brain. The 
extrapolation of this information to mice would be in order. 
There are other effects of M0911 which could modify its total 
activity. These diverse effects are present in other MAO inhibitors 
of different structure. Rorowitz and Sjoerds111a (1961) demonstrated a 
decrease in sympathetic nerve activity. Costa and Brodie {1961) also 
noted similar effects by pretreating with M0911 and then following with 
Ford (1961), and Decosta et al. (1961). The mitigating influences of 
these physiological responses on .gross locomotor activity are apparent. 
Any of these alone or in combination could reduce a gross effect to 
the limits of a measuring instrument. These factors were not controlled 
in this experiment. Efforts to control these factors would present 
serious problems in evaluating the results of in vivo locomotor studies. 
Combined therapy of thyroid and MAO inhibitor did not signif i-
cantly alter locomotor activity {see Table 5 and Figures 14-16). The 
response noted by Kline (1961) of retardation and apathy was not dµp-
licated with mice. Since the retardation has been demonstrated only 
in depressed humans, a similar alteration of .the psyche must be induced 
in experimental animals for duplication of this response. Tl\ere has 
been no documentation of normal patients responding to thyroid and MAO 
inhibitor medication in this manner. 
In all of the actophotometer studies, fluctuations from the con-
trol values were evident on particular days. None of the departures 
from the normal or control values were significant. Trends were not 
established and the fluctuations were random. Since all animals i.n a 
45. 
particular section were handled under the same conditions, it is ap-
parent that the drugs did not alter locomotor responses in a signif i-
cant manner. 
The method of Creasey (1956) and Hawkins (1952) was satisfactory 
in measuring MAO activity manometrically. 
oxygen uptake of mice liver mitochondria-microsome as a measure 
of MAO activity after thyroid treatment was linear with time (Figure 2). 
The coefficient of correlation was 0.99, indicating a high degree of 
linear association. The coefficient of determination indicates that 
97 percent of the variations occurring in o2 uptake can be explained 
on the basis of the linear regression of oxygen uptake with time. 
Total oxygen consumptions was 45.6 pl for 28 minutes (Table 1). 
Respiration of control .mice liver mitochondria for the thyroid 
experiment also indicates linearity with time (Figure 3). The co-
efficient of correlation was 0.98. Variation of the dependent vari-
able could be explained by the variation of the independent as dem-
onstrated by the calculated value of o.96. Oxygen uptake was 45.4 pl 
for 28 minutes (Table 1). 
W~th the aid of covariance analysis (Snedecor, 1956), the prob-
ability that the two regression lines are in fact the same line is 99 
percent. Since these lines also possess the same slopes, this suggests 
that the regression lines are not different. The total oxygen uptake 
per hour for the thyroid treated animasl would be 100.4 pl o2• The 
experimental consumption was not significantly different from the con-
trol value of 101.1 pl o2• 
These values do not agree with Spinks and Burn (1952), Zile and 
Lardy (1959). Skillen et al. (1962) found that thyroid decreases MAO 
activity in rat liver. Novick (1961) also found that thyroid decreases 
46. 
MAO activity 50 percent below that of controls. Zile (1960) found in-
significant changes in brain and heart MAO activity with thyroxine and 
related compounds and that increased dosages did not elicit a more pro-
found effect. 
One theory concerning the mechanism of action of thyroid on MAO 
is that thyroid decreases enzyme levels indirectly. Zile and Lardy 
(1959) suggest that thyroid regulates the biosynthesis of MAO or con-
trols the enzymes that govern the activity of MAO in the liver. 
Westermann (1956) found an increase in MAO following thyroid 
feeding in rat livers. 
It is apparent that no definite statement can be made concern-
ing the effects of thyroid on MAO activity in rodents. Barker's (1951) 
observation that thyroid feeding even with supportive vitamin therapy 
produces changes in the liver not attributable to thyroid alone may 
have valid application. If there are changes in the physiology of the 
liver, the differences in MAO activity may not accurately reflect change,~ 
produced by drug administration. 
Mice liver mitochondria-microsomes, removed from M0911 treated 
animals, showed reduced respiration linear with time (Figure 4). Total 
oxygen uptake was 5.6 pl/hr. The coefficient of correlation was 0.79 
and the coefficient of determination 0.62. The latter coefficient size . 
is indicative of influences of factors other than the independent vari-
able influencing the regression line. 
The oxygen uptake by the control animals was also linear (see 
Figure 5). The coefficient of correlation was 0.93 constituting an ex-
cellent correlation. The unexplained variation was 13 percent which is 
relatively small. 
47. 
Reduction in liver MAO activity by M0911 has been reported by 
Taylor et al. (1960). The results of this experiment corroborate 
Taylor's work. 
The decrease in MAO activity ot mice liver mi tochondira was l.8 
times that of the controls (Table 1). It is apparent that M0911 is a 
powerful MAO inhibitor and that significant decrease in MAO levels can 
be achieved and maintained by daily injections. 
Combined therapy of M0911 and thyroid reduced MAO activity of 
livers significantly over the controls (see Figure 6). Total activjty 
of treated livers was determined to be 38 pl o2 per hour as opposed to 
the control value of 113 pl o2 per hour (see Figure 7). Comparing the 
results of combined therapy with K:>911 therapy, a six fold increase in 
MAO activity is observed (see Table 1). This suggests that thyroid 
antagonizes the effects of M0911 in liver. 
The fact that thyroid elicits no change in MAO activity but sup-
presses the total effect of M:>911 may indicate a specific mechanism of 
action. Thyroid, a metabolic stimulator, apparently causes an in-
creased turnover of constituents in the cell . The ability of an exo-
genous inhibitor of an enzyme system to exercise its usual effect may 
be reduced . This may be caused by increased synthesis of the enzyme 
or the inability of the inhibitor to reach the substrate in an ef-
fective concentration. The result would be increased activity of the 
enzyme when combined thyroid and MAO inhibitor therapy is utilized. 
Brain mitochondrial .MAO activity after thyroid administration 
[ 
was variable (~able 2). Enzyme levels were lower in two groups with 
percentage decreases of 81 percent and 24 percent. The third experi-
mental group showed a 30 percent increase in MAO activit y. 'lbe re-
48. 
fractory response of the latter group cannot be explained in terms of 
penetration of the aeblood brain barrier .. by thyroid since two groups 
did show definite decreases in MAO activity. These results agree with 
Zile (1960), who stated that the changes in MAO activity in brain after 
thyroid feeding were insignificant and inconsistent. 
There is no reason to suggest that the increase in MAO activity 
is an artifact. Apparently, this is an individual response with obscure 
prerequisite cell constituents which would predetermine whether an in-
crease or decrease in MAO activity is observed. 
M'.>911 therapy decreased Ml\0 activity in three experimental groups. 
Several investigators have observed a decrease in brain MAO activity 
after M0911 therapy, including Taylor et al. (1960; l960a), Wiegand 
and Perry (1961), and Baronde~ (1962). In our investigation enzyme 
activity declined 100 percent, 97 percent and 75 percent of control 
values. This indicated that there is no impediment for access of M0911 
to active sites of enzyme inhibition in the brain. 
Thyroid and M09ll therapy .did not differ from M0911 alone in its 
effects on MAO depletion in brain tissue. The experimental groups 
sho'Wed decreases of 100 percent, 83 percent and 77 percent in activity 
(see Table 2). It is apparent that no augmentation of effect or antag-
onistic response occurred at .this level. Apparently, if any changes in 
the metabolism of the catecholamines are to be shown, another enzyme 
system, possibly the CDMT system, may be involved. 
Since the brain is such a complex system, other modifications 
in function cannot be overlooked. Changes in other systems could ac-
count for the retardation and apathy observed in patients. 
VI. SUMMARY AND CX>NCLUSIONS 
The interrelationships of thyroid, MAO, and locomotor responses 
have been investigated. 
Locomotor activity of mice was evaluated by the use of acto-
photometers. The administration of thyroid, M0911, a MAO inhibitor, 
and combined thyroid and M0911 therapy, did not alter spontaneous ac-
tivity significantly. 
The apathetic response was not produced in mice with combined 
thyroid and M09ll administration. Reasons for the lack of response by 
the experimental animals were discussed. 
MAO activity was measured manometrically using the Warburg ap-
paratus. MAO activity, measured by uptake of oxygen, was shown to vary 
with the administration of thyroid, M0911, and combined thyroid and 
M0911. MAO activity could not be correlated with locomotor activity 
since spontaneous activity was not affected by the administration of 
the drugs employed. 
Brain MAO activity did not show consistency after drug adminis-
tration. MAO activity decreased in two groups but increased in one 
group after the administration of thyroid, !-1>911, and combined M0911 
and thyroid. 
M0911 treated animals exhibited no change in locomotor activity 
but significant decreases of MAO .activity in brain and liver were ob-
served. Combined therapy of M0911 and thyroid resulted in an increase 
in MAO activity in livers above that of M0911 and below thyroid admin-
istered separately. The increase in MAO activity with combined therapy 
indicates that thyroid antagonizes MAO inhibitors outside the central 
nervous system. 
49 
so. 
The central action of thyroid differs from its peripheral activity 
in that brain mitochondria MAO w•s lowered on the average. Apparently, · 
thyroid action is nd:direct and the presence or absence of intermediates 
determine observed r~sults. 
Since combination therapy did not show a aifference in MAO activ-
ity from M0911 therapy tissue, the response previously noted in humans, 
retardation and apathy , could not be ascribed to changes in MAO activ-
ity in the brain. 
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VIII. APPENDIX 
Constants for total oxygen uptake were calculated by the use of 
the formula: 
Vg (273) + Vf 
k= T 
Po 
Vg = volume of gas phase in flask including connecting tubes. 
T = temperature of bath in absolute degrees. 
Vf = volume of fluid in vessel. 
= solubility in reaction liquid of gas involved. Expressed as ml 
gas/ml liquid when the gas is at a pressure of 760 mm Hg at the 
temperature T. 
P0 = standard pressure. (Brodie's solution is equivalen to 10,000 mm 
Hg.) 
The method the least squares was used for regression lines for 
· the manometric plots and the regression line relationships were calcu-
lated according to Lewis (1953). 
zy =Na+ bX 
z.xy = ax + bz.;c2 
R0 the null hypothesis stating that the regression line is not 
a sample from the universe from which it is drawn. 
r 
t = r2-u 
r 
S =J (Y-Yc)2 
y N 
1 - sy2 yz r = 
56 
standard error of the regres-
sion 
critical ratio 
scatter 
coefficient of correlation 
S7. 
coefficient of determiua~ 
tion 
